Related Experiment Video
Updated: Dec 10, 2025

08:55
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
15.8K
The Parkinson's Disease Genome-Wide Association Study Locus Browser
Francis P Grenn1, Jonggeol J Kim1, Mary B Makarious1
1Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
Movement Disorders : Official Journal of the Movement Disorder Society
|September 1, 2020
Summary
Researchers developed a Parkinson's disease (PD) genome-wide association study browser tool. This tool helps identify potential causal genes at known PD risk loci, aiding in the discovery of new therapeutic targets.
Area of Science:
- Genetics
- Neuroscience
- Bioinformatics
Background:
- Parkinson's disease (PD) is a complex neurodegenerative disorder with numerous genetic risk variants identified through genome-wide association studies (GWAS).
- Identifying the specific causal genes and variants within these GWAS loci remains a significant challenge in PD research.
- Over 90 independent risk variants across 80 genomic regions have been linked to PD risk and progression.
Purpose of the Study:
- To develop a bioinformatics tool to display data for Parkinson's disease (PD) risk loci.
- To provide guidance for prioritizing causal genes and understanding potential mechanisms at each PD GWAS locus.
- To facilitate the identification of potential therapeutic targets for Parkinson's disease.
Main Methods:
- Integrated data from multiple large-scale PD GWAS, including risk, age-at-onset, progression, and Asian population studies.
- Collected data for genes within a 1 Mb window upstream and downstream of each significant GWAS variant.
- Queried multiple databases to gather comprehensive causal data for each gene.
Main Results:
- Developed and launched a Parkinson's disease GWAS browser tool (https://pdgenetics.shinyapps.io/GWASBrowser/).
- The tool enables researchers to assess gene-variant associations based on user-defined criteria.
- Facilitates the prioritization of genes for functional studies to identify potential therapeutic targets.
Conclusions:
- The PD GWAS browser tool offers a valuable resource for the research community.
- It aids in identifying potential causal genes at known PD risk loci from large-scale GWAS.
- The tool will be updated with new data as PD research advances and more risk loci are discovered.
Related Concept Videos
Genome-wide Association Studies-GWAS
15.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.1K
Single Nucleotide Polymorphisms-SNPs
17.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K

